Search research articles
Contact Us
Filters
Showing results (61-70 of 79) with videos related to
Page
of 8
Sort By:
Neuroreport
|
July 28, 1997
(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease
A Ekesbo, P E Andrén, L M Gunne, et al.
Journal of Neural Transmission
|
January 1, 1983
Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias
J E Häggström, L M Gunne, A Carlsson, et al.
European Journal of Clinical Pharmacology
|
August 1, 1979
Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady state
E Anggård, M I Nilsson, J Holmstrand, et al.
Acta Psychiatrica Scandinavica
|
January 1, 1977
Thyrotropin-releasing hormone (TRH) inchronic schizophrenia. A controlled study
L H Lindström, L M Gunne, L G Ost, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1973
Amphetamine metabolism in amphetamine psychosis
E Anggård, L E Jönsson, A L Hogmark, et al.
Pharmacology, Biochemistry, and Behavior
|
October 1, 1993
Modulation of oral movements by intranigral 5-hydroxytryptamine receptor agonists in the rat
U Liminga, A E Johnson, P E Andrén, et al.
Psychopharmacology
|
February 1, 1996
High frequency oral movements induced by long-term administration of amperozide but not FG5803 in rats
U Liminga, P E Andren, L S Ohlund, et al.
European Journal of Pharmacology
|
February 26, 2000
Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions
A Ekesbo, P E Andrén, L M Gunne, et al.
Acta Psychiatrica Scandinavica
|
February 1, 1978
Endorphins in human cerebrospinal fluid: clinical correlations to some psychotic states
L H Lindström, E Widerlöv, L M Gunne, et al.
L'Encephale
|
September 1, 1988
Neurobiochemical changes in tardive dyskinesia
L M Gunne, J E Häggström, P Johansson, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 79) with videos related to
Sort By:
Page
of 8
Neuroreport
|
July 28, 1997
(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease
A Ekesbo, P E Andrén, L M Gunne, et al.
Journal of Neural Transmission
|
January 1, 1983
Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias
J E Häggström, L M Gunne, A Carlsson, et al.
European Journal of Clinical Pharmacology
|
August 1, 1979
Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady state
E Anggård, M I Nilsson, J Holmstrand, et al.
Acta Psychiatrica Scandinavica
|
January 1, 1977
Thyrotropin-releasing hormone (TRH) inchronic schizophrenia. A controlled study
L H Lindström, L M Gunne, L G Ost, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1973
Amphetamine metabolism in amphetamine psychosis
E Anggård, L E Jönsson, A L Hogmark, et al.
Pharmacology, Biochemistry, and Behavior
|
October 1, 1993
Modulation of oral movements by intranigral 5-hydroxytryptamine receptor agonists in the rat
U Liminga, A E Johnson, P E Andrén, et al.
Psychopharmacology
|
February 1, 1996
High frequency oral movements induced by long-term administration of amperozide but not FG5803 in rats
U Liminga, P E Andren, L S Ohlund, et al.
European Journal of Pharmacology
|
February 26, 2000
Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions
A Ekesbo, P E Andrén, L M Gunne, et al.
Acta Psychiatrica Scandinavica
|
February 1, 1978
Endorphins in human cerebrospinal fluid: clinical correlations to some psychotic states
L H Lindström, E Widerlöv, L M Gunne, et al.
L'Encephale
|
September 1, 1988
Neurobiochemical changes in tardive dyskinesia
L M Gunne, J E Häggström, P Johansson, et al.
Page
of 8